Journal article

Introduction of lamivudine for the treatment of chronic hepatitis B: Expected clinical and economic outcomes based on 4-year clinical trial data

S Crowley, D Tognarini, P Desmond, M Lees, G Saal

Journal of Gastroenterology and Hepatology | WILEY | Published : 2002

DOI: 10.1046/j.1440-1746.2002.02673.x

Citation metrics

38Web of Science
38Scopus

Keywords

Hepatitis B, Chronic
Lamivudine
Science & Technology
Liver
Decision Support Techniques
Models, Economic
Health Care Costs
Markov Chains
Survival
Interferon-Alpha
Cirrhosis Type-B
Multicenter
Cost-Benefit Analysis
Australia
Clinical Trials As Topic
Cost-Effectiveness
Infection
Hbeag
Humans
Natural-History
Decision Analysis
Life Sciences & Biomedicine
Alpha-Interferon
Gastroenterology & Hepatology
Interferon Therapy
Models, Statistical
Antiviral Agents
Prognostic Factors
Chronic Hepatitis B
Disease Progression